From: Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Diabetes group | Control group | |||||
---|---|---|---|---|---|---|
esRAGE baseline | esRAGE follow-up | sRAGE baseline | esRAGE baseline | esRAGE follow-up | sRAGE baseline | |
esRAGE follow-up | 0.396 | 1 | 0.636 | 1 | ||
sRAGE baseline | 0.800 | 0.295 | 1 | 0.775 | 0.597 | 1 |
sRAGE follow-up | 0.593 | 0.510 | 0.638 | 0.458 | 0.828 | 0.620 |